Human leptin levels are pulsatile and inversely related to pituitary - Adrenal function

Nature Medicine

Volumn 3, Issue 5, 1997, Pages 575-579

  Licinio, Julio ^a   Mantzoros, Christos ^b   Negråo', André B ^a   Cizza, Giovanni ^a,c   Wong, Ma L I ^a   Bongiorno, Peter B ^a   Chrousos, George P ^c   Karp, Brian ^a   Allen, Christine ^d   Flier, Jeffrey S ^b   Gold, Philip W ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEPTIN;

ADRENAL GLAND; ARTICLE; BLOOD LEVEL; CASE REPORT; CIRCADIAN RHYTHM; FEMALE; HUMAN; HYPOPHYSIS; MALE; NORMAL HUMAN; NUTRITIONAL STATUS; OBESITY; PRIORITY JOURNAL; REGULATORY MECHANISM;

EID: 16944364768     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm0597-575     Document Type: Article

References (30)

1. Zhang, Y. et al. Positional cloning of the mouse obese gene and its human homologue. Nature 372, 425-432 (1994).
2. Spiegelman, B.M. & Flier, J.S. Adipogenesis and obesity: Rounding out the big picture. Cell 87, 377-389 (1996).
3. Ahima, R.S. et al. Role of leptin in the neuroendocrine response to fasting. Nature 382, 250-252 (1996).
4. Chehab, F.F., Lim, M.E. & Lu R. Correction of the sterility defect in homozygous obese female mice by treatment with the human recombinant leptin. Nature Genet, 12, 318-320 (1996).
5. Oerter, K.E., Guardabasso, V. & Rodbard, D. Detection and characterization of peaks and estimation of instantaneous secretory rate for episodic pulsatile hormone secretion. Comput. Biomed. Res. 19, 170-191 (1986).
6. Houseknecht, K.R. et al. Evidence for the existence of leptin binding to proteins in serum of rodents and humans: Modulation with obesity. Diabetes 45, 1638-1643 (1996).
7. Veldhuis, J.D. & Johnson, M.L. Cluster analysis: A simple, versatile, and robust algorithm for endocrine pulse detection. Am. J. Physiol. 250, E486-493 (1986).
8. Licinio, J. et al. Twenty-four hour concentrations of circulating interleukin-2 in healthy women exhibit episodic fluctuations: Analysis of integrated basal levels and discrete pulse properties. Endocrine 1, 120-128 (1993).
9. Sinha, M.K. et al. Nocturnal rise of leptin in lean, obese, and non-insulin-dependent diabetes mellitus subjects. J. Clin. Invest. 97, 1344-1347 (1996).
10. Jenkins, G.M. & Watts, D.G. Spectral Analysis and Its Applications. (Holden Day, San Francisco, CA, 1968).
11. Chrousos, G.P. et al. The corticotropin-releasing factor stimulation test: An aid in the evaluation of patients with Cushing's syndrome. N. Engl. J. Med. 310, 622-626 (1984).
12. Sutton, R.E., Koob, G.F., LeMoal, M., Rivier, J. & Vale, W. Corticotropin-releasing factor produces behavioural activation in rats. Nature 297, 331-333 (1982).
13. Gold P.W., Kaye, W., Robertson, G.L. & Ebert, M. Abnormalities in plasma and cerebrospinal-fluid arginine vasopressin in patients with anorexia nervosa. N. Engl. J. Med. 308, 1117-1123 (1983).
14. Gold, P.W. et al. Responses to corticotropin-releasing hormone in the hypercortisolism of depression and Cushing's disease: Pathophysiologic and diagnostic implications. N. Engl. J. Med. 314, 1329-1335 (1986).
15. Fehm, W.G., Bachholz, G., Born, J., Voigt, K. & Fehm, H.L. Vasopressin but not oxytocin enhances cortical arousal: An integrative hypothesis on behavioral effects of neurohypophyseal hormones. Psychopharmacology (Berl) 94, 496-500 (1988).
16. Schwartz, M.W., Seeley, R.J., Campfield, L.A., Burn, P. & Baskin, D.G. Identification of targets of leptin action in rat hypothalamus. J. Clin. Invest. 98, 1101-1106 (1996).
17. Schwartz, M.W., Dallman, M.F. & Woods, S.C. Hypothalamic response to starvation: Implications for the study of wasting disorders. Am. J. Physiol. 269, R949-R957 (1995).
18. Sinha, M.K. et al. Ultradian oscillations of leptin secretion in humans. Biochem. Biophys. Res. Commun. 228, 733-738 (1996).
19. Homburg, R. et al. One hundred pregnancies after treatment with pulsatile luteinising hormone releasing hormone to induce ovulation. Er. Med. J. 298, 809-812 (1989).
20. Zinaman, M.J., Cartledge, T., Tomai, T., Tippett, P. & Merriam, G.R. Pulsatile GnRH stimulates normal cyclic ovarian function in amenorrheic lactating postpartum women. J. Clin. Endocrinol. Metab. 80, 2088-2093 (1995).
21. Aulizky, W., Frick, J. & Hadziselimovic, F. Pulsatile LHRH therapy in patients with oligozoospermia and disturbed LH pulsatility. Int. J. Androl. 12, 265-272 (1989).
22. Turzillo, A.M., Juengel, J.L & Nett, T.M. Pulsatile gonadotropin-releasing hormone (GnRH) increases concentrations of GnRH receptor messenger ribonucleic acid and numbers of GnRH receptors during luteolysis in the ewe. Biol. Reprod. 53, 418-423 (1995).
23. Haisenleder, D.J., Ortolano, G.A., Yasin, M., Dalkin, A.C. & Marshall, J.C. Regulation of gonadotropin subunit messenger ribonucleic acid expression by gonadotropinreleasing hormone pulse amplitude in vitro. Endocrinology 132, 1292-1296 (1993).
24. Haisenleder, D.J., Dalkin, A.C., Ortolano, G.A., Marshall, J.C. & Shupnik, M.A. A pulsatile gonadotropin-releasing hormone stimulus is required to increase transcription of the gonadotropin subunit genes: Evidence for differential regulation of transcription by pulse frequency in vivo. Endocrinology 128, 509-517 (1991).
25. Veldhuis, J.D. The hypothalamic pulse generator: The reproductive core. Clin. Obstet. Gynecol. 33, 538-550 (1990).
26. Maiter, D., Underwood, I.E., Maes, M., Davenport, M.L & Ketelslegers, J.M. Different effects of intermittent and continuous growth hormone (GH) administration on serum somatomedin-C/insulin-like growth factor I and liver GH receptors in hypophysectomized rats, Endocrinology 123, 1053-1059 (1988).
27. López-Fernández, J. et al. Growth hormone induces somatostatin and insulin-like growth factor I gene expression in the cerebral hemispheres of aging rats. Endocrinology 137, 4384-4391 (1996).
28. Glaum, S.R. et al. Leptin, the obese gene product, rapidly modulates synaptic transmission in the hypothalamus. Mol. Pharmacol. 50, 230-235 (1996).
29. Campfield, L.A., Smith, F.J., Guisez, Y., Devos, R. & Burn, P. Recombinant mouse OB protein: Evidence for a peripheral signal linking adiposity and central neural networks. Science 269, 546-549 (1995).
30. Michelson, D. et al. Multiple sclerosis is associated with alterations in hypothalamic-pituitary-adrenal axis function. J. Clin. Endocrinol. Metab. 79, 848-853 (1994).